Moomoo AI 已提取核心訊息
Assembly Biosciences, Inc. (ASMB) has announced a reverse stock split that is scheduled to take effect before the market opens on February 12, 2024. The split will be conducted on a 1-for-12 basis, meaning that each common share of ASMB will be converted into the right to receive approximately 0.083333 new common shares of Assembly Biosciences. Shareholders will receive cash in lieu of fractional shares that result from the split. Concurrently, the option symbol for Assembly Biosciences will change from ASMB to ASMB1. The new CUSIP number for the post-split shares will be 045396207. The cash in lieu amount for fractional shares will be determined and settled through the National Securities Clearing Corporation (NSCC), with the Options Clearing Corporation (OCC) delaying settlement of the cash portion until the amount is finalized. The OCC will then require put exercisers and call assignees to deliver the appropriate cash amount.
Assembly Biosciences, Inc. (ASMB) has announced a reverse stock split that is scheduled to take effect before the market opens on February 12, 2024. The split will be conducted on a 1-for-12 basis, meaning that each common share of ASMB will be converted into the right to receive approximately 0.083333 new common shares of Assembly Biosciences. Shareholders will receive cash in lieu of fractional shares that result from the split. Concurrently, the option symbol for Assembly Biosciences will change from ASMB to ASMB1. The new CUSIP number for the post-split shares will be 045396207. The cash in lieu amount for fractional shares will be determined and settled through the National Securities Clearing Corporation (NSCC), with the Options Clearing Corporation (OCC) delaying settlement of the cash portion until the amount is finalized. The OCC will then require put exercisers and call assignees to deliver the appropriate cash amount.
Assembly Biosciences, Inc.（ASMB）宣佈了反向股票拆分，計劃於2024年2月12日市場開盤前生效。拆分將以1比12的方式進行，這意味着ASMB的每股普通股將轉換爲獲得約0.083333股Assembly Biosciences新普通股的權利。股東將獲得現金來代替拆分產生的部分股份。同時，Assembly Biosciences的期權符號將從ASMB更改爲 ASMB1。拆分後股票的新CUSIP號碼將爲045396207。部分股份的現金替代金額將通過國家證券清算公司（NSCC）確定和結算，期權清算公司（OCC）將現金部分的結算推遲到金額最終確定之後。然後，OCC將要求看跌期權使用者和看漲受讓人提供適當的現金金額。
Assembly Biosciences, Inc.（ASMB）宣佈了反向股票拆分，計劃於2024年2月12日市場開盤前生效。拆分將以1比12的方式進行，這意味着ASMB的每股普通股將轉換爲獲得約0.083333股Assembly Biosciences新普通股的權利。股東將獲得現金來代替拆分產生的部分股份。同時，Assembly Biosciences的期權符號將從ASMB更改爲 ASMB1。拆分後股票的新CUSIP號碼將爲045396207。部分股份的現金替代金額將通過國家證券清算公司（NSCC）確定和結算，期權清算公司（OCC）將現金部分的結算推遲到金額最終確定之後。然後，OCC將要求看跌期權使用者和看漲受讓人提供適當的現金金額。
有用
沒用
該公告為獨立文件：